← FDA Drug Approvals (Drugs@FDA)

FULVESTRANT

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: HBT LABS INC · Approved 2019-11-21

Drug application

FDA Application #

ANDA209714

Application type

Abbreviated New Drug Application (Generic)

Brand name

FULVESTRANT

Generic name

FULVESTRANT

Active ingredients

FULVESTRANT

Dosage form

SOLUTION

Route

INTRAMUSCULAR

Marketing status

Prescription

Sponsor

HBT LABS INC

Manufacturer

Meitheal Pharmaceuticals Inc

First approval

2019-11-21

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown